Published in Schizophr Res on May 01, 2003
North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull (2007) 3.28
Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ (2013) 3.06
Early intervention for psychosis. Cochrane Database Syst Rev (2011) 3.04
The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry (2005) 1.52
Antipsychotic medication for early episode schizophrenia. Cochrane Database Syst Rev (2011) 1.49
Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. J Cogn Neurosci (2007) 1.28
Prediction and prevention of schizophrenia: what has been achieved and where to go next? World Psychiatry (2011) 1.15
Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother (2010) 1.10
Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull (2008) 1.07
An automated method to analyze language use in patients with schizophrenia and their first-degree relatives. J Neurolinguistics (2010) 1.07
Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur Neuropsychopharmacol (2008) 1.06
Indicated prevention of schizophrenia. Dtsch Arztebl Int (2008) 1.06
Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophr Bull (2007) 1.02
Neurological soft signs predict abnormal cerebellar-thalamic tract development and negative symptoms in adolescents at high risk for psychosis: a longitudinal perspective. Schizophr Bull (2013) 1.00
Application of electroencephalography to the study of cognitive and brain functions in schizophrenia. Schizophr Bull (2007) 0.96
Comorbidity of physical and mental disorders in the neurodevelopmental genomics cohort study. Pediatrics (2015) 0.95
Early detection of schizophrenia: current evidence and future perspectives. World Psychiatry (2006) 0.94
Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia. J Child Adolesc Psychopharmacol (2008) 0.89
Evaluating and treating the prodromal stage of schizophrenia. Curr Psychiatry Rep (2004) 0.88
Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia. Neuroimage Clin (2014) 0.85
Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophr Bull (2014) 0.85
Attentional modulation of early-stage visual processing in schizophrenia. Brain Res (2006) 0.82
Early intervention in schizophrenia. Indian J Psychiatry (2008) 0.80
Treating early psychosis: who, what, and when? Dialogues Clin Neurosci (2005) 0.79
Ethical concerns in schizophrenia research: looking back and moving forward. Schizophr Bull (2005) 0.79
Gender difference in the prodromal symptoms of first-episode schizophrenia. J Korean Med Sci (2009) 0.79
Is pharmacological intervention necessary in prodromal schizophrenia? Shanghai Arch Psychiatry (2012) 0.79
Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications. Neuropsychiatr Dis Treat (2005) 0.78
Rationale and parameters for medication-free research in psychosis. Schizophr Bull (2006) 0.78
Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls - first steps in development of a biomarker. BMC Med (2015) 0.75
Cognitive behavioral therapy in prodromal psychosis. Curr Pharm Des (2012) 0.75
A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol (1994) 5.47
One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry (1994) 5.29
Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry (2008) 4.14
WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res (2000) 4.07
A depression rating scale for schizophrenics. Schizophr Res (1991) 3.70
Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA (2000) 3.52
Multicenter collaborative panic disorder severity scale. Am J Psychiatry (1997) 3.29
Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl (1993) 3.24
Symptom assessment in schizophrenic prodromal states. Psychiatr Q (1999) 3.09
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br J Cancer (1992) 2.91
Cognitive effects of corticosteroids. Am J Psychiatry (1990) 2.85
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry (2000) 2.66
An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Ann Intern Med (1999) 2.56
Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res (1992) 2.49
A real-time ratiometric method for the determination of molecular oxygen inside living cells using sol-gel-based spherical optical nanosensors with applications to rat C6 glioma. Anal Chem (2001) 2.48
Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. 1993. Psychiatr Serv (2000) 2.43
CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR Am J Neuroradiol (1999) 2.43
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry (2000) 2.34
Structure of 3' terminal region of type II human T lymphotropic virus: evidence for new coding region. Science (1984) 2.32
A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr (1979) 2.32
Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcohol Clin Exp Res (1992) 2.25
Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology (1997) 2.20
The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry (1987) 2.19
Childhood abuse in first-episode psychosis. Br J Psychiatry (1994) 2.17
Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry (1999) 2.15
Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst (2001) 2.09
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry (2012) 2.07
A novel augmentation strategy for treating resistant major depression. Am J Psychiatry (2001) 2.05
Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet (1997) 2.02
Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am J Psychiatry (1998) 2.00
Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res (2000) 1.98
Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex. Psychophysiology (1991) 1.95
The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry (2001) 1.94
5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry (1998) 1.94
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry (2000) 1.93
Embryonic-fetal erythroid characteristics of a human leukemic cell line. Proc Natl Acad Sci U S A (1980) 1.90
Infarctlike lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly--data from the Cardiovascular Health Study. Radiology (1997) 1.90
NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology (1996) 1.88
A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol (2001) 1.86
Role of members of the Wnt gene family in human hematopoiesis. Blood (1998) 1.86
Extent of comorbidity between mental state and personality disorders. J Pers Disord (1997) 1.81
The Vermont longitudinal study of persons with severe mental illness, I: Methodology, study sample, and overall status 32 years later. Am J Psychiatry (1987) 1.80
Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin. J Clin Invest (1977) 1.79
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol (2001) 1.79
Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression. JAMA (1990) 1.78
Nucleotide sequence and genome organization of canine parvovirus. J Virol (1988) 1.76
Human CD34(+) stem cells express the hiwi gene, a human homologue of the Drosophila gene piwi. Blood (2001) 1.74
The treatment of lead poisoning from gunshot wounds with succimer (DMSA) J Toxicol Clin Toxicol (1994) 1.72
Cerebral gray matter and white matter volume deficits in adolescent girls with anorexia nervosa. J Pediatr (1996) 1.69
Early intervention in psychosis: keeping faith with evidence-based health care. Psychol Med (2009) 1.64
Effects of fixed-ratio sample and choice response requirements upon oddity matching. J Exp Anal Behav (1977) 1.63
Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatry (1999) 1.63
Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol (1988) 1.62
Impact of folivory on photosynthesis is greater than the sum of its holes. Proc Natl Acad Sci U S A (2002) 1.61
Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand (2002) 1.60
The relationship between panic disorder and major depression. A new family study. Arch Gen Psychiatry (1993) 1.59
Unipolar mania reconsidered: evidence from an elderly cohort. Br J Psychiatry (1994) 1.57
Effects of response-produced stimuli upon conditional discrimination performance. J Exp Anal Behav (1974) 1.57
Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry (1993) 1.55
Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab (1997) 1.55
The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO Study). Pharmacoepidemiologic Study of Olanzapine in Schizophrenia. J Clin Psychiatry (2000) 1.54
Depressive symptoms and the deficit syndrome of schizophrenia. J Nerv Ment Dis (1994) 1.54
Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results. Arch Gen Psychiatry (1988) 1.53
Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr Bull (2001) 1.53
Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma. Bone Marrow Transplant (2006) 1.52
Co-morbidity and familial aggregation of alcoholism and anxiety disorders. Psychol Med (1998) 1.52
Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand (2011) 1.52
Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am J Psychiatry (1998) 1.51
Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry (1994) 1.49
Gender and affect in schizophrenia. Can J Psychiatry (1996) 1.47
Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. Arch Gen Psychiatry (1989) 1.47
Factorial structure of the Scale of Prodromal Symptoms. Schizophr Res (2004) 1.47
Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital. Community Ment Health J (1995) 1.45
The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study. J Clin Psychiatry (1999) 1.45
First-episode schizophreniform disorder: comparisons with first-episode schizophrenia. Schizophr Res (2000) 1.44
The rapid isolation of ribonuclease-free immunoglobulin G by protein A-sepharose affinity chromatography. J Immunol Methods (1978) 1.44
Postpartum onset of panic disorder: a coincidental event? J Clin Psychiatry (1993) 1.44
Increasing frequency of the diagnosis of obsessive-compulsive disorder. Am J Psychiatry (1992) 1.43
Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes. Am J Hematol (1992) 1.43
2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia. Blood (2000) 1.43
Prolonged duration of operation: an indicator of complicated surgery or of surgical (mis)management? Infection (2011) 1.42
Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr Res (2004) 1.42
Proteins released from liver after ischaemia induced an elevation of heart resistance against ischaemia-reperfusion injury: 1. Beneficial effect of protein fraction isolated from perfusate after ischaemia and reperfusion of liver. Gen Physiol Biophys (2003) 1.41
Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia. J Clin Oncol (1997) 1.41
Enriched hematopoietic stem cells: basic biology and clinical utility. Biol Blood Marrow Transplant (1995) 1.41
Fauna of Catal Hüyük: evidence for early cattle domestication in Anatolia. Science (1969) 1.41
Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med (1985) 1.41
First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe. Arch Gen Psychiatry (1998) 1.40
Successful use of recombinant activated factor VII (Novoseven) in controlling severe intra-abdominal bleeding after liver needle biopsy. Thromb Haemost (2002) 1.40
Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. Am J Psychiatry (1993) 1.40